Compare $KALA vs $VSBC | Chartloom

Compare

$KALA vs $VSBC

KALA BIO Inc · Vitaspring Biomedical Co. Ltd

KALA

KALA BIO Inc

VSBC

Vitaspring Biomedical Co. Ltd

Compare $KALA vs $VSBC

Comparing KALA BIO Inc and Vitaspring Biomedical Co. Ltd

KALAKALA BIO Inc

VSBCVitaspring Biomedical Co. Ltd

KALAKALA BIO Inc

Market cap

$6M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-99.1%

52W performance

-99.6%

FCF yield

-349.4%

VSBCVitaspring Biomedical Co. Ltd

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-100.0%

52W performance

-100.0%

FCF yield

0.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KALA

VSBC

Detailed metrics comparison

KALA

KALA BIO Inc

VSBC

Vitaspring Biomedical Co. Ltd

Market Cap

KALA$6M

VSBC$7M

Enterprise Value

KALA$5M

VSBC$9M

Price

KALA$0.29

VSBC$0.00

P/E Ratio

KALAN/A

VSBCN/A

P/S Ratio

KALA1.29x

VSBC0.99x

EV/Sales

KALA1.26x

VSBC0.99x

EV/EBITDA

KALA0.00x

VSBC4.29x

P/B Ratio

KALA0.82x

VSBC3.92x

P/FCF Ratio

KALAN/A

VSBC765.53x

EV/FCF

KALA-0.27x

VSBC1,044.32x

PEG Ratio

KALAN/A

VSBCN/A

Forward P/E (NTM)

KALAN/A

VSBCN/A

Forward P/S (NTM)

KALAN/A

VSBCN/A

Revenue (TTM)

KALA$0

VSBC$0

Revenue Growth (YoY)

KALAN/A

VSBCN/A

Forward Rev Growth

KALA0.0%

VSBC0.0%

Gross Margin (TTM)

KALA31.0%

VSBC39.3%

Operating Margin (TTM)

KALA0.0%

VSBC23.4%

EBITDA Margin (TTM)

KALA0.0%

VSBC0.0%

Net Margin (TTM)

KALA0.0%

VSBC18.2%

FCF Margin (TTM)

KALAN/A

VSBCN/A

Net Income (TTM)

KALA$-10M

VSBC$-456K

FCF (TTM)

KALA$-20M

VSBC$9K

EPS (TTM)

KALA-$135.85

VSBC-$0.00

ROE (TTM)

KALA-2816.0%

VSBC70.0%

ROA (TTM)

KALA-7023.0%

VSBC-211240.0%

ROIC (TTM)

KALA-2816.0%

VSBC70.0%

Cash

KALA$229K

VSBC$13K

Debt

KALA$0

VSBC$2M

Net Cash/Debt

KALA$229K

VSBC$-2M

Current Ratio (TTM)

KALA6.88x

VSBC0.00x

Quick Ratio (TTM)

KALA4.84x

VSBC0.00x

Debt/Equity (TTM)

KALA2.47x

VSBC0.00x

Debt/Assets (TTM)

KALA0.0%

VSBC0.0%

Interest Coverage (TTM)

KALAN/A

VSBCN/A

Net Debt/EBITDA (TTM)

KALA0.00x

VSBC0.00x

Beta

KALA-2.48

VSBC-1.47

52W Performance

KALA-99.6%

VSBC-100.0%

YTD Performance

KALA-99.1%

VSBC-100.0%

% from 52W High

KALA-99.7%

VSBC-100.0%

% from 52W Low

KALA2.8%

VSBCN/A

Asset Turnover (TTM)

KALA0.05x

VSBC2.66x

FCF Yield (TTM)

KALA-349.4%

VSBC0.1%

Earnings Yield (TTM)

KALA-177.3%

VSBC-6.9%

Dividend Yield (TTM)

KALAN/A

VSBCN/A

Rule of 40

KALA0.0

VSBC0.0

EV/GP/RG

KALAN/A

VSBCN/A

Ticker research

View KALA research View VSBC research

Metric	KALA KALA BIO Inc	VSBC Vitaspring Biomedical Co. Ltd
Market & Valuation
Market Cap	$6M	$7M
Enterprise Value	$5M	$9M
Price	$0.29	$0.00
P/E Ratio	N/A	N/A
P/S Ratio	1.29x	0.99x
EV/Sales	1.26x	0.99x
EV/EBITDA	0.00x	4.29x
P/B Ratio	0.82x	3.92x
P/FCF Ratio	N/A	765.53x
EV/FCF	-0.27x	1,044.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	31.0%	39.3%
Operating Margin (TTM)	0.0%	23.4%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	18.2%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-10M	$-456K
FCF (TTM)	$-20M	$9K
EPS (TTM)	-$135.85	-$0.00
ROE (TTM)	-2816.0%	70.0%
ROA (TTM)	-7023.0%	-211240.0%
ROIC (TTM)	-2816.0%	70.0%
Financial Health
Cash	$229K	$13K
Debt	$0	$2M
Net Cash/Debt	$229K	$-2M
Current Ratio (TTM)	6.88x	0.00x
Quick Ratio (TTM)	4.84x	0.00x
Debt/Equity (TTM)	2.47x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.48	-1.47
52W Performance	-99.6%	-100.0%
YTD Performance	-99.1%	-100.0%
% from 52W High	-99.7%	-100.0%
% from 52W Low	2.8%	N/A
Efficiency & Yields
Asset Turnover (TTM)	0.05x	2.66x
FCF Yield (TTM)	-349.4%	0.1%
Earnings Yield (TTM)	-177.3%	-6.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View KALA research	View VSBC research

Valuation

P/S Ratio

VSBC

0.99x

KALA

1.29x

EV/FCF

KALA

-0.27x

VSBC

1,044.32x

Growth & revenue

Forward Revenue Growth

KALA

0.0%

VSBC

0.0%

Profitability & performance

Gross Margin

VSBC

39.3%

KALA

31.0%

ROE

VSBC

70.0%

KALA

-2816.0%

FCF Yield %

VSBC

0.1%

KALA

-349.4%

52-Week Performance

KALA

-99.6%

VSBC

-100.0%

Detailed metrics comparison

KALA

KALA BIO Inc

VSBC

Vitaspring Biomedical Co. Ltd

Market Cap

KALA$6M

VSBC$7M

Enterprise Value

KALA$5M

VSBC$9M

Price

KALA$0.29

VSBC$0.00

P/E Ratio

KALAN/A

VSBCN/A

P/S Ratio

KALA1.29x

VSBC0.99x

EV/Sales

KALA1.26x

VSBC0.99x

EV/EBITDA

KALA0.00x

VSBC4.29x

P/B Ratio

KALA0.82x

VSBC3.92x

P/FCF Ratio

KALAN/A

VSBC765.53x

EV/FCF

KALA-0.27x

VSBC1,044.32x

PEG Ratio

KALAN/A

VSBCN/A

Forward P/E (NTM)

KALAN/A

VSBCN/A

Forward P/S (NTM)

KALAN/A

VSBCN/A

Revenue (TTM)

KALA$0

VSBC$0

Revenue Growth (YoY)

KALAN/A

VSBCN/A

Forward Rev Growth

KALA0.0%

VSBC0.0%

Gross Margin (TTM)

KALA31.0%

VSBC39.3%

Operating Margin (TTM)

KALA0.0%

VSBC23.4%

EBITDA Margin (TTM)

KALA0.0%

VSBC0.0%

Net Margin (TTM)

KALA0.0%

VSBC18.2%

FCF Margin (TTM)

KALAN/A

VSBCN/A

Net Income (TTM)

KALA$-10M

VSBC$-456K

FCF (TTM)

KALA$-20M

VSBC$9K

EPS (TTM)

KALA-$135.85

VSBC-$0.00

ROE (TTM)

KALA-2816.0%

VSBC70.0%

ROA (TTM)

KALA-7023.0%

VSBC-211240.0%

ROIC (TTM)

KALA-2816.0%

VSBC70.0%

Cash

KALA$229K

VSBC$13K

Debt

KALA$0

VSBC$2M

Net Cash/Debt

KALA$229K

VSBC$-2M

Current Ratio (TTM)

KALA6.88x

VSBC0.00x

Quick Ratio (TTM)

KALA4.84x

VSBC0.00x

Debt/Equity (TTM)

KALA2.47x

VSBC0.00x

Debt/Assets (TTM)

KALA0.0%

VSBC0.0%

Interest Coverage (TTM)

KALAN/A

VSBCN/A

Net Debt/EBITDA (TTM)

KALA0.00x

VSBC0.00x

Beta

KALA-2.48

VSBC-1.47

52W Performance

KALA-99.6%

VSBC-100.0%

YTD Performance

KALA-99.1%

VSBC-100.0%

% from 52W High

KALA-99.7%

VSBC-100.0%

% from 52W Low

KALA2.8%

VSBCN/A

Asset Turnover (TTM)

KALA0.05x

VSBC2.66x

FCF Yield (TTM)

KALA-349.4%

VSBC0.1%

Earnings Yield (TTM)

KALA-177.3%

VSBC-6.9%

Dividend Yield (TTM)

KALAN/A

VSBCN/A

Rule of 40

KALA0.0

VSBC0.0

EV/GP/RG

KALAN/A

VSBCN/A

Ticker research

View KALA research View VSBC research

Metric	KALA KALA BIO Inc	VSBC Vitaspring Biomedical Co. Ltd
Market & Valuation
Market Cap	$6M	$7M
Enterprise Value	$5M	$9M
Price	$0.29	$0.00
P/E Ratio	N/A	N/A
P/S Ratio	1.29x	0.99x
EV/Sales	1.26x	0.99x
EV/EBITDA	0.00x	4.29x
P/B Ratio	0.82x	3.92x
P/FCF Ratio	N/A	765.53x
EV/FCF	-0.27x	1,044.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	31.0%	39.3%
Operating Margin (TTM)	0.0%	23.4%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	18.2%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-10M	$-456K
FCF (TTM)	$-20M	$9K
EPS (TTM)	-$135.85	-$0.00
ROE (TTM)	-2816.0%	70.0%
ROA (TTM)	-7023.0%	-211240.0%
ROIC (TTM)	-2816.0%	70.0%
Financial Health
Cash	$229K	$13K
Debt	$0	$2M
Net Cash/Debt	$229K	$-2M
Current Ratio (TTM)	6.88x	0.00x
Quick Ratio (TTM)	4.84x	0.00x
Debt/Equity (TTM)	2.47x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.48	-1.47
52W Performance	-99.6%	-100.0%
YTD Performance	-99.1%	-100.0%
% from 52W High	-99.7%	-100.0%
% from 52W Low	2.8%	N/A
Efficiency & Yields
Asset Turnover (TTM)	0.05x	2.66x
FCF Yield (TTM)	-349.4%	0.1%
Earnings Yield (TTM)	-177.3%	-6.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View KALA research	View VSBC research